Canaccord Genuity Maintains Buy on Braze, Lowers Price Target to $40

Benzinga Newsdesk www.benzinga.com Negative 74.3%

Neg 74.3% Neu 0% Pos 0%

Canaccord Genuity analyst David Hynes maintains Braze (NASDAQ:BRZE) with a Buy and lowers the price target from $43 to $40.